
Oncoplastic breast conserving surgery for breast cancer is practical, effective and very desirable in low and middle income country settings, new research study finds.

Luciano Costa MD PhD ASH 2025

Aromatase inhibitor adjuvant hormone therapy for women with ER+ HER2- early breast cancer performed better than adjuvant treatment with a selective estrogen receptor modifier such as tamoxifen


A seective estrogen degrader out-performed AI's in ER+ HER- early breast cancer

Financial Disaster from curative treatment for childhood ALL

Dramatic Cures for Children with No Prospects Using Standard Therapies for T-cell malignancies

Some patients being treated for stage three colon cancer could avoid the use of chemotherapy and be spared toxicities such as neuropathy: according to a study in which ctDNA liquid biopsy monitoring for the return of the disease was carried out.

Aan identifyable subset of patients with high-risk ER+ HER2- early breast cancer better off without chemotherapy

Antibody Drug Conjugate Prolongs Life in NSCLC refractory to EGFR TKI Therapy
ADC beats SOC in previously treated Advanced Breast Cancer